Cuprina Holdings (Cayman) (CUPR) Stock Price, News & Analysis

Company Overview

Cuprina Holdings (Cayman) Limited is a healthcare company focused on the development and commercialization of wound-care products. The company operates through subsidiaries and is associated with the Cuprina brand of medical products.

Cuprina’s business centers on wound-management solutions, including products designed to support the treatment and healing of wounds. Its offerings are based in part on medical-grade honey and other naturally derived ingredients used in wound-care applications.

The company has roots in Singapore and serves the healthcare market through activities that include product development, regulatory work, commercialization, and distribution. Publicly available information about its broader geographic operations and leadership is limited.

Key Stats

• Today's Range: $1.69 to $1.79
• 50-Day Range: $1.60 to $4.33
• 52-Week Range: $1.45 to $14.80
• Volume: 94,705 shs
• Average Volume: 115,367 shs
• Market Capitalization: $1.65 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Cuprina Holdings (Cayman) Stock Analysis - MarketRank™

Cuprina Holdings (Cayman) scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Cuprina Holdings (Cayman) has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Cuprina Holdings (Cayman) has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Cuprina Holdings (Cayman) has a P/B Ratio of 1.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.12% of the float of Cuprina Holdings (Cayman) has been sold short.

Short Interest Ratio / Days to Cover

Cuprina Holdings (Cayman) has a short interest ratio ("days to cover") of 0.09, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cuprina Holdings (Cayman) has recently decreased by 90.32%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cuprina Holdings (Cayman) does not currently pay a dividend.

Dividend Growth

Cuprina Holdings (Cayman) does not have a long track record of dividend growth.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.22

News Sentiment

Cuprina Holdings (Cayman) has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Cuprina Holdings (Cayman) this week, compared to 2 articles on an average week.

Search Interest

1 people have searched for CUPR on MarketBeat in the last 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cuprina Holdings (Cayman) insiders have not sold or bought any company stock.

Percentage Held by Institutions

Cuprina Holdings (Cayman) has minimal institutional ownership at this time.

Company Calendar

• Today: 9/20/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:CUPR
• CIK: 1995704
• Web: www.cuprina.com.sg
• Phone: (658) 512-7275
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.07
• Current Ratio: 2.35
• Quick Ratio: 2.35

Sales & Book Value

• Annual Sales: $40 thousand
• Price / Sales: 41.17
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.50 per share
• Price / Book: 1.19

Miscellaneous

• Outstanding Shares: 920,000
• Free Float: N/A
• Market Cap: $1.65 million
• Optionable: N/A
• Beta: -0.37